Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
7.53
-0.19 (-2.46%)
At close: Apr 28, 2026, 4:00 PM EDT
7.53
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Shattuck Labs Revenue
In the year 2025, Shattuck Labs had annual revenue of $1.00M, down -82.52%.
Revenue (ttm)
$1.00M
Revenue Growth
-82.52%
P/S Ratio
574.42
Revenue / Employee
$25,000
Employees
40
Market Cap
569.13M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CorMedix | 311.71M |
| Rigel Pharmaceuticals | 294.28M |
| Zevra Therapeutics | 106.47M |
| Prothena Corporation | 9.68M |
| Aclaris Therapeutics | 7.83M |
| Adlai Nortye | 5.00M |
| Ocugen | 4.41M |
| ProKidney | 893.00K |
STTK News
- 7 weeks ago - Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Shattuck Labs Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Shattuck Labs Announces Participation in Upcoming March Investor Conferences - GlobeNewsWire
- 2 months ago - Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium - GlobeNewsWire
- 4 months ago - Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - Shattuck Labs Transcript: Evercore ISI 8th Annual HealthCONx Conference - Transcripts
- 5 months ago - Shattuck Labs Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts
- 5 months ago - Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy - Benzinga